Oman
Industry
BMI View: Diabetes and cardiovascular diseases are the Middle East and North Africa (MENA)'s biggest epidemiological challenge. The underlying cause of these diseases is obesity. The...
2012-02-06Industry
BMI View: Attempts in the Gulf region to take a more preventative stance against public health issues is commendable, but changing attitudes and weaning the population of their tobacco...
2012-02-01Industry
BMI View: While the biotechnology parks of Dubai and Saudi Arabia have attracted some big names in the global industry, we are concerned that they may have become glorified tax havens...
2011-11-09Industry
BMI View: A free trade agreement (FTA) between India and the Gulf Cooperation Council (GCC) will help Indian drugmakers to take a greater market share of the generic drug segment, primarily...
2011-10-13Industry
BMI View: The impact of the Arab Spring across the region has forced Oman to increase public healthcare expenditure. However, due to the relatively small population and economy this...
2011-09-13Industry
BMI View: The formation of The Gulf Federation of Manufacturers of Pharmaceuticals and Medical Supplies (GFMPMS) in Doha is, potentially, a very significant move towards the regulatory...
2011-06-13Industry
In line with our core view that emerging markets will drive industry growth, Qatar First Investment Bank (QFIB) and Dubai-based Ithmar Capital, a regional private equity firm, have...
2010-06-15Industry
Oman Pharmaceutical Products (OPP) has announced that recent US FDA approval for one of its antibiotic products will result in the drug's export to the US in due course. The Oman-based...
2010-05-10
